Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 375 entries
View as:

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

Phase: N/A Priority: Normal
NCT ID: NCT02651883 Org: User:
Start: 04/30/16 End: 04/10/20 Due: 04/10/21

Comparison of the Sensitivity and Specificity of Acoustic Angiography to the Sensitivity and Specificity of Conventional Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT02175628 Org: User:
Start: 06/30/14 End: 06/30/18 Due: 06/30/19

Enhancing Source Credibility in Tobacco Regulatory Communications

Phase: N/A Priority: Normal
NCT ID: NCT03339206 Org: User:
Start: 10/10/17 End: 05/23/18 Due: 05/23/19

An Evaluation of the Families Addressing Cancer Together (FACT) Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04342871 Org: User:
Start: 10/05/20 End: 07/27/21 Due: 07/27/22

Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00334438 Org: User:
Start: 07/31/06 End: 10/31/11 Due: 10/31/12

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01175967 Org: User:
Start: 06/30/10 End: 05/31/15 Due: 05/31/16

Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN

Phase: N/A Priority: Normal
NCT ID: NCT02124707 Org: User:
Start: 06/16/14 End: 10/01/19 Due: 10/01/20

Academic-Industrial Partnership for Translation of Acoustic Angiography

Phase: N/A Priority: Normal
NCT ID: NCT03544268 Org: User:
Start: 03/25/19 End: 05/25/21 Due: 05/25/22

Impact of Vaping Prevention Advertisements

Phase: N/A Priority: Normal
NCT ID: NCT04836455 Org: User:
Start: 07/03/21 End: 11/03/21 Due: 11/03/22

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01234467 Org: User:
Start: 03/31/11 End: 08/31/16 Due: 08/31/17

Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities

Phase: N/A Priority: Normal
NCT ID: NCT04990934 Org: User:
Start: 07/02/21 End: 10/10/21 Due: 10/10/22

UNC Pleural Fluid Registry

Phase: N/A Priority: Normal
NCT ID: NCT05620329 Org: User:
Start: 01/24/18 End: 01/24/50 Due: 01/24/51

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02660710 Org: User:
Start: 03/31/16 End: 07/22/22 Due: 07/22/23

Exercise and Quality of Life in Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT02246907 Org: User:
Start: 01/31/14 End: 12/31/15 Due: 12/31/16

Connecting Audio and Radio Sensing Systems to Improve Care at Home

Phase: N/A Priority: Normal
NCT ID: NCT05344950 Org: User:
Start: 03/21/22 End: 07/31/24 Due: 07/31/25

Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01305954 Org: User:
Start: 12/31/10 End: 09/25/23 Due: 09/25/24

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04243941 Org: User:
Start: 11/29/22 End: 02/07/24 Due: 02/07/25

Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04092816 Org: User:
Start: 10/30/19 End: 06/06/22 Due: 06/06/23

Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00280150 Org: User:
Start: 01/31/06 End: 01/31/13 Due: 01/31/14

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT02684461 Org: User:
Start: 09/13/16 End: 11/19/21 Due: 11/19/22

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Phase: N/A Priority: Normal
NCT ID: NCT05440929 Org: User:
Start: 07/07/22 End: 08/10/25 Due: 08/10/26

mPATH-Cloud for Colorectal Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT06441487 Org: User:
Start: 06/24/25 End: 01/01/29 Due: 01/01/30

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03694834 Org: User:
Start: 03/29/19 End: 10/23/23 Due: 10/23/24

Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim

Phase: N/A Priority: Normal
NCT ID: NCT00280787 Org: User:
Start: 11/30/03 End: 10/31/10 Due: 10/31/11

Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

Phase: N/A Priority: Normal
NCT ID: NCT01605344 Org: User:
Start: 04/30/12 End: 07/31/14 Due: 07/31/15